AI in Medical Writing Market Size

AI in Medical Writing Market Size

AI in Medical Writing Market size was valued at USD 758.7 million in 2023 and is expected to exhibit growth at a CAGR of 13.1% from 2024 to 2032. The growth of AI in medical writing is attributed to increasing focus on streamlining of medical writing, extensive growth in medical data, and introduction of intelligent generative AI software solutions.

To get key market trends

  Download Free Sample

Furthermore, the market is primarily driven by the growing need for efficiency and accuracy in clinical documentation. Traditional medical writing processes are often labor-intensive and prone to errors, particularly when dealing with large volumes of data. AI technologies, such as natural language processing (NLP) and machine learning algorithms, streamline the documentation process by automating repetitive tasks, ensuring consistency, and reducing human error. This enhancement in accuracy is crucial in regulatory environments. As the healthcare sector continues to expand, the demand for AI-driven solutions in medical writing is expected to rise exponentially during the forecast period.
 

In addition, the adoption of AI in medical writing is also projected to witness considerable growth due to emphasis on regulatory compliance and standardization. Regulatory bodies such as the FDA and EMA have stringent requirements for documentation in clinical trials and regulatory submissions. AI technologies help to ensure that medical documents adhere to these regulations by automating compliance checks and standardizing formats. Due to this requirement, the market players are also introducing intelligent solutions to accommodate the needs of writing standards. For instance, in June 2024, TrialAssure announced launch of TrialAssure LINK AI 2.0 medical writing software to assist pharmaceutical companies in regulatory writing. Such developments are expected to propel market growth.
 

AI in medical writing refers to the use of artificial intelligence technologies to automate and enhance the creation, management, and analysis of medical documents, including clinical trial reports, regulatory submissions, and patient education materials.